|
|
||||||||
1 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224-6801; and 2 Departments of Medicine, Physiology and Biophysics, Indiana University School of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana 46202
NaF, a potent G protein activator and Ser/Thr phosphatase inhibitor, significantly increased albumin permeability and decreased transcellular electrical resistance (TER), indicating endothelial cell (EC) barrier impairment. EC barrier dysfunction induced by NaF was accompanied by the development of actin stress fibers, intercellular gap formation, and significant time-dependent increases in myosin light chain (MLC) phosphorylation. However, despite rapid, albeit transient, activation of Ca2+/calmodulin-dependent MLC kinase (MLCK), the specific MLCK inhibitor ML-7 failed to affect NaF-induced MLC phosphorylation, actin cytoskeletal rearrangement, and reductions in TER, suggesting a limited role of MLCK in NaF-induced EC activation. In contrast, strategies to reduce Rho (C3 exoenzyme or toxin B) or to inhibit Rho-associated kinase (Y-27632 or dominant/negative RhoK) dramatically reduced MLC phosphorylation and actin stress fiber formation and significantly attenuated NaF-induced EC barrier dysfunction. Consistent with this role for RhoK activity, NaF selectively inhibited myosin-specific phosphatase activity, whereas the total Ser/Thr phosphatase activity remained unchanged. These data strongly suggest that MLC phosphorylation, mediated primarily by RhoK, and not MLCK, participates in NaF-induced EC actin cytoskeletal changes and barrier dysfunction.
Rho-associated kinase; myosin-specific phosphatase; transendothelial electrical resistance; actin cytoskeletal rearrangement; myosin light chain
This article has been cited by other articles:
![]() |
F. Houle, A. Poirier, J. Dumaresq, and J. Huot DAP kinase mediates the phosphorylation of tropomyosin-1 downstream of the ERK pathway, which regulates the formation of stress fibers in response to oxidative stress J. Cell Sci., October 15, 2007; 120(20): 3666 - 3677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Csortos, I. Kolosova, and A. D. Verin Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. V. Bogatcheva, P. Wang, A. A. Birukova, A. D. Verin, and J. G. N. Garcia Mechanism of fluoride-induced MAP kinase activation in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1139 - L1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Harrington, J. Newton, N. Morin, and S. Rounds Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1091 - L1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Adamson, M. Zeng, G. N. Adamson, J. F. Lenz, and F. E. Curry PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H406 - H417. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Houle, S. Rousseau, N. Morrice, M. Luc, S. Mongrain, C. E. Turner, S. Tanaka, P. Moreau, and J. Huot Extracellular Signal-regulated Kinase Mediates Phosphorylation of Tropomyosin-1 to Promote Cytoskeleton Remodeling in Response to Oxidative Stress: Impact on Membrane Blebbing Mol. Biol. Cell, April 1, 2003; 14(4): 1418 - 1432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |